权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Training Grant in Cancer Biology

癌症生物学培训补助金

基本信息

批准号：
8268435
负责人：
William Stratford MAY
金额：
$ 36.58万
依托单位：
UNIVERSITY OF FLORIDA
依托单位国家：
美国
项目类别：
财政年份：
1997
资助国家：
美国
起止时间：
1997-09-24 至 2014-05-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8268435
关键词：
Cancer Biology Grant Training

项目摘要

DESCRIPTION (provided by applicant): The University of Florida has a long and productive history in cancer research and care of cancer patients. We seek to competitively renew our T32 Cancer Biology Training Grant, (CBTG) currently in its 30th consecutive year of funding. The overall goal of the Cancer Biology Training Program is to prepare our post- and pre-doctoral trainees for a successful cancer research career by providing expert and comprehensive mentoring in the laboratory. Some significant changes have been made. These include the continued development of the University of Florida Shands Cancer Center (UFSCC) with recruitment of additional cancer focused research faculty who have become members of the CBTG faculty. In addition, the construction of a new Cancer and Genetics Research Building that adds 284,000 sq. ft. of new basic and translational research space is now complete and available for occupancy in June, 2006. The building is the largest research building on the campus of the University of Florida and is shared by investigators in the UFSCC and UF Genetics Institute, thus bringing together and forging a deeper critical mass of cancer-focused researchers. The Cancer Biology Training Program outlined in this competitive continuation application (i.e., years 31-35) has the faculty expertise, infrastructure, resources and cancer- focused research opportunities to continue to provide an outstanding training environment. A special emphasis is on the training of MD, MD/PhD or PhD post-doctoral, as well as pre-doctoral PhD or MD/PhD candidates, who plan to pursue careers in academic oncology and cancer research that involve basic and translational studies. Our program has demonstrated outstanding success of its trainees. Most have remained in academic positions and have made contributions of new knowledge that lead to discovery and development of novel treatments, diagnosis or prevention measures for patients with cancer. In addition, we continue to actively encourage and recruit diversity among our trainees. Finally, to help ensure our commitment to the clinical-translation of basic science discoveries and to take advantage of the NIH's new policy of recognizing dual PIs, Maureen Goodenow, Ph.D. has been appointed Co-PI of the T32 Training Grant in Cancer Biology by the current PI, W. Stratford May, Jr., M.D., Ph.D.

描述(由申请者提供)：佛罗里达大学在癌症研究和癌症患者护理方面有着悠久而富有成效的历史。我们寻求竞争性地续签我们的T32癌症生物学培训助学金(CBTG)，目前已连续第30年获得资助。癌症生物学培训计划的总体目标是通过在实验室提供专家和全面的指导，为我们的博士后和博士后培训人员为成功的癌症研究生涯做好准备。已经做出了一些重大的改变。这些措施包括继续发展佛罗里达大学斯汉兹癌症中心(UFSCC)，招聘更多专注于癌症的研究教员，他们已经成为CBTG教员。此外，还将建造一座新的癌症和遗传学研究大楼，面积增加284,000平方米。英国《金融时报》新的基础和翻译研究空间现已建成，并于2006年6月投入使用。这座大楼是佛罗里达大学校园内最大的研究大楼，由UFSCC和UF遗传学研究所的研究人员共享，从而聚集并打造了一批更深层次的癌症研究人员。在这份竞争性续展申请中概述的癌症生物学培训计划(即31-35年)拥有教师专业知识、基础设施、资源和专注于癌症的研究机会，以继续提供出色的培训环境。特别重视对医学博士、医学博士/博士或博士后以及博士前博士或医学博士/博士候选人的培训，这些人计划从事涉及基础和翻译研究的学术肿瘤学和癌症研究。我们的项目已经展示了学员们的杰出成就。大多数人仍在学术岗位上，并做出了新知识的贡献，为癌症患者发现和开发了新的治疗、诊断或预防措施。此外，我们继续积极鼓励和招募学员的多样性。最后，为了帮助确保我们对基础科学发现的临床转化的承诺，并利用NIH承认双重PI的新政策，Maureen Goodenow博士被现任PI任命为T32癌症生物学培训补助金的联合PI，W.Stratford May，Jr.，M.D.，Ph.D.